STAND. COM. REP. NO. 423-18
RE: H.B. No. 2384
Honorable Scott K. Saiki
Speaker, House of Representatives
Twenty-Ninth State Legislature
Regular Session of 2018
State of Hawaii
Your Committee on Health & Human Services, to which was referred H.B. No. 2384 entitled:
"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"
begs leave to report as follows:
The purpose of this measure is to amend the Uniform Controlled Substances Act to provide flexibility and clear guidance for practitioners who prescribe, administer, or dispense controlled substances for patients undergoing medically managed withdrawal or detoxification treatment.
Specifically, the measure:
(1) Excludes certain substances from Schedule II to conform with the Federal Drug Enforcement Administration's updated schedules of controlled substances; and
(2) Establishes registration and compliance requirements for medical practitioners and hospitals that prescribe, administer, and dispense controlled substances to patients undergoing medically managed withdrawal.
Your Committee has amended this measure by:
(1) Changing its effective date to July 1, 3000, to promote further discussion; and
(2) Making technical, nonsubstantive amendments for clarity, consistency, and style.
Your Committee notes the testimony by the Hawaii Substance Abuse Coalition which viewed certain sections as contradicting each other and proposed the expansion of prescriptive authority to include substances classified under Schedule II. Should your Committee on Judiciary consider this measure, your Committee respectfully requests that it consider these concerns.
As affirmed by the record of votes of the members of your Committee on Health & Human Services that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2384, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 2384, H.D. 1, and be referred to your Committee on Judiciary.
Respectfully submitted on behalf of the members of the Committee on Health & Human Services,
JOHN M. MIZUNO, Chair